-
2023-508125-27-00
4
2025-04-01
Bipolar disorder- depressive episode
-
2024-520305-39-00
4
2025-04-01
Chronic cluster headache
-
2022-501489-24-00
5
2025-03-28
First-line treatment of adult subjects with high-risk large B-cell lym
-
2023-506128-10-00
4
2025-03-27
Cerebral amyloid angiopathy
-
2023-510354-16-00
11
2025-03-06
HIV infection
-
2023-509748-89-00
7
2025-02-19
Facioscapulohumeral muscular dystrophy (FSHD)
-
2023-509256-34-00
7
2025-02-06
Alpha-1 Antitrypsin Deficiency (AATD)-Associated Lung Disease and/or L
-
2024-517547-31-00
1
2025-01-31
Rheumatoid Arthritis
-
2024-510697-24-00
10
2025-01-02
mpox (earlier: monkey pox)
-
2024-516125-31-02
9
2024-12-18
Metastatic Melanoma
-
2024-516937-10-01
5
2024-12-18
Melanoma
-
2023-510150-17-00
4
2024-12-11
Active, refractory systemic lupus erythematosus (SLE), and active, re
-
2023-510380-34-00
4
2024-12-10
Diffuse cutaneous systemic sclerosis (dcSSc)
-
2024-513092-40-00
6
2024-12-05
Stroke
-
2023-508558-25-01
9
2024-12-02
Type 1 Diabetes
-
2024-514055-15-00
6
2024-11-19
Pulmonary sarcoidosis
-
2024-511823-32-00
4
2024-11-06
Duchenne muscular dystrophy (DMD)
-
2022-502972-22-00
5
2024-10-31
Clostridioides difficile infection.
-
2023-509465-20-00
5
2024-10-28
metastatic pancreatic cancer
-
2023-510186-98-00
6
2024-10-23
Venous thromboembolism
-
2023-504144-33-01
11
2024-10-17
esophageal cancer
-
2024-512553-25-00
3
2024-10-15
Rejection transplanted kidney
-
2023-506115-17-00
5
2024-10-14
Metastatic Colorectal Cancer
-
2024-514620-17-00
4
2024-10-14
Patients with early-stage rectal cancer (defined as early rectal cance